Tag: Cas13

Lack of Cas13a inhibition by anti-CRISPR proteins from Leptotrichia prophages

Summary CRISPR systems are prokaryotic adaptive immune systems that use RNA-guided Cas nucleases to recognize and destroy foreign genetic elements. To overcome CRISPR immunity, bacteriophages have evolved diverse families of anti-CRISPR proteins (Acrs). Recently, Lin et al. (2020) described the discovery and characterization of 7 Acr families (AcrVIA1–7) that inhibit…

Continue Reading Lack of Cas13a inhibition by anti-CRISPR proteins from Leptotrichia prophages

Top 5 CRISPR Companies To Invest In

The CRISPR Revolution There are hundreds and even thousands of diseases that have a root cause in genetics. Many of these are to this day untreatable or poorly treated. And most are either heavily incapacitating or deadly. While some gene modification technology has been around since the 1990s, they were…

Continue Reading Top 5 CRISPR Companies To Invest In

RPA-CRISPR/Cas12a mediated isothermal amplification for visual detection of Phytophthora sojae

Introduction Phytophthora sojae is among the most destructive pathogens of soybean (Glycine max). An estimated annual worldwide loss of US$1–2 billion is caused by P. sojae, which was first identified as a soybean pathogen in the 1950s in Indiana, Ohio, and North Carolina (Schmitthenner, 1985; Tyler, 2007; Dorrance, 2018). The…

Continue Reading RPA-CRISPR/Cas12a mediated isothermal amplification for visual detection of Phytophthora sojae

Multi-faceted CRISPR/Cas technological innovation aspects in the framework of 3P medicine

Golubnitschaja O, Baban B, Boniolo G, Wang W, Bubnov R, Kapalla M, et al. Medicine in the early twenty-first century: paradigm and anticipation – EPMA position paper 2016. EPMA J. 2016;7:23. Article  PubMed  PubMed Central  Google Scholar  Kropp M, Golubnitschaja O, Mazurakova A, Koklesova L, Sargheini N, Vo T-TKS, et…

Continue Reading Multi-faceted CRISPR/Cas technological innovation aspects in the framework of 3P medicine

Oxford Nanopore Technologies Unveils New Direct RNA Sequencing Chemistry

NEW YORK – Oxford Nanopore Technologies said on Thursday that it is rolling out a new direct RNA sequencing kit that the company promises will “significantly” increase the raw read accuracy as well as data output. While Oxford Nanopore has been known for its relatively rapid product turnover for DNA applications,…

Continue Reading Oxford Nanopore Technologies Unveils New Direct RNA Sequencing Chemistry

Precision Targeting of Na-K-2Cl cotransporter (NKCC1) RNA In Vitro with RfxCas13d

Abstract The Na-K-2Cl cotransporter (NKCC1) is considered an attractive drug target in the Central nervous system (CNS) for treating various CNS disorders. However, the specific role of NKCC1 in different types following injury within the CNS is not well understood due to its expression in multiple cell types. Additionally, there…

Continue Reading Precision Targeting of Na-K-2Cl cotransporter (NKCC1) RNA In Vitro with RfxCas13d

CRISPR-Cas13 guide RNA predictor for transcript depletion

Cite As: Krohannon A, Srivastava M, Rauch S, Srivastava R, Dickinson BC, Janga SC. CASowary: CRISPR-Cas13 guide RNA predictor for transcript depletion. BMC Genomics. 2022;23(1):172. Published 2022 Mar 2. doi:10.1186/s12864-022-08366-2 Abstract: Background: Recent discovery of the gene editing system – CRISPR (Clustered Regularly Interspersed Short Palindromic Repeats) associated proteins (Cas),…

Continue Reading CRISPR-Cas13 guide RNA predictor for transcript depletion

Potential of CRISPR/Cas system as emerging tools in the detection of viral hepatitis infection | Virology Journal

Tapper EB, Curry MP. Hepatitis Caused by Other Viruses Handbook of Liver Disease, 2018: p. 78. Sarin SK, Kumar M. Viral hepatitis A, in Molecular Pathology of Liver Diseases. Springer; 2011. pp. 527–52. Qu B, Brown RJ. Strategies to inhibit Hepatitis B Virus at the transcript level. Viruses. 2021;13(7):1327. Article  CAS …

Continue Reading Potential of CRISPR/Cas system as emerging tools in the detection of viral hepatitis infection | Virology Journal

Genome Editing Market to Reach USD 15.7BN by 2032, Growing at a CAGR of 15.2%, Rising Prevalence of Genetic Disorders

Reports And Data Genome editing market size was USD 3.8 Billion in 2022 and is expected to reach USD 15.7 Billion by 2032, and CAGR of 15.2% during the forecast period The global genome editing market size was USD 3.8 Billion in 2022 and is expected to reach USD 15.7…

Continue Reading Genome Editing Market to Reach USD 15.7BN by 2032, Growing at a CAGR of 15.2%, Rising Prevalence of Genetic Disorders

Highly sensitive and facile microRNA detection based on target triggered exponential rolling-circle amplification coupling with CRISPR/Cas12a

MicroRNAs (miRNAs) are small noncoding RNAs consisting of approximately 20–25 nucleotides. As a kind of transcription regulation factors, miRNAs perform post-transcriptional repression by binding to the 3′UTR of target in the seed region, which is considered as a typical mode of miRNA-mediated gene regulation [[1], [2], [3]]. And they play…

Continue Reading Highly sensitive and facile microRNA detection based on target triggered exponential rolling-circle amplification coupling with CRISPR/Cas12a

Study uncovers new clues and raises more questions about CRISPR

CRISPR claimed scientific fame for its ability to quickly and accurately edit genes. But, at the core, CRISPR systems are immune systems that help bacteria protect themselves from viruses by targeting and destroying viral DNA and RNA. A new study published in Science reveals a previously unrecognized player in one…

Continue Reading Study uncovers new clues and raises more questions about CRISPR

Development and characterization of a digital CRISPR/Cas13a based assay for rapid and sensitive diagnosis of Severe Fever with Thrombocytopenia Syndrome Virus

Following the first reports of Severe fever with thrombocytopenia syndrome virus (SFTSV) during 2009 in Central China [1], there have been outbreaks reported in over 20 Chinese provinces in subsequent years [2], as well as SFTSV cases reported in Japan [3] and Korea [4]. The early, non-specific clinical symptoms of…

Continue Reading Development and characterization of a digital CRISPR/Cas13a based assay for rapid and sensitive diagnosis of Severe Fever with Thrombocytopenia Syndrome Virus

Genome-wide tiled detection of circulating Mycobacterium tuberculosis cell-free DNA using Cas13,Nature Communications

Detection of microbial cell-free DNA (cfDNA) circulating in the bloodstream has emerged as a promising new approach for diagnosing infection. Microbial diagnostics based on cfDNA require assays that can detect rare and highly fragmented pathogen nucleic acids. We now report WATSON (Whole-genome Assay using Tiled Surveillance Of Nucleic acids), a…

Continue Reading Genome-wide tiled detection of circulating Mycobacterium tuberculosis cell-free DNA using Cas13,Nature Communications

RPA/CRISPR-cas12a as a specific, sensitive and rapid method for diagnosing Ehrlichia canis and Anaplasma platys in dogs in Thailand

Almazán C, González-Álvarez VH, Fernández de Mera IG, Cabezas-Cruz A, Rodríguez-Martínez R, De la Fuente J (2016) Molecular identification and characterization of Anaplasma platys and Ehrlichia canis in dogs in Mexico. Ticks Tick Borne Dis 7:276–283. doi.org/10.1016/j.ttbdis.2015.11.002 Article  PubMed  Google Scholar  Aman R, Mahas A, Marsic T, Hassan N, Mahfouz…

Continue Reading RPA/CRISPR-cas12a as a specific, sensitive and rapid method for diagnosing Ehrlichia canis and Anaplasma platys in dogs in Thailand

CSIRO hiring CSIRO Postdoctoral Fellowship in Anti-Viral Bioinformatics in Sydney, New South Wales, Australia

Acknowledgement of CountryCSIRO acknowledges the Traditional Owners of the land, sea and waters, of the area that we live and work on across Australia. We acknowledge their continuing connection to their culture and pay our respects to their Elders past and present. View our vision towards reconciliation The Opportunity Do…

Continue Reading CSIRO hiring CSIRO Postdoctoral Fellowship in Anti-Viral Bioinformatics in Sydney, New South Wales, Australia

Collateral activity of the CRISPR/RfxCas13d system in human cells

Cell culture HEK293T, MEF-1, and U87 cell lines were used in this research. HEK293T was purchased from ATCC. MEF-1, and U87 cell lines were gifts from Muredach P. Reilly, Peter A. Sims, respectively. HEK293T, MEF-1, and U87 cells were cultured in DMEM with 4.5 g/L D-Glucose, supplemented with 10% fetal bovine…

Continue Reading Collateral activity of the CRISPR/RfxCas13d system in human cells

Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2

Affiliations Expand Affiliations 1 Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands. 2 Department of Molecular and Cell Biology, National Center of Biotechnology (CNB-CSIC), Campus Universidad Autónoma de Madrid, 28049 Madrid, Spain. Free PMC article Item in…

Continue Reading Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2

Genome Editing Tool Looks Beyond CRISPR and Prime

Omar Abudayyeh, PhD, McGovern fellow at MIT’s McGovern Institute for Brain Research A recently patented genome editing tool called PASTE holds genuine promise for expanding the universe of treatable genetic diseases. The approach combines elements of CRISPR and prime editing with a pair of enzymes designed to enable the integration…

Continue Reading Genome Editing Tool Looks Beyond CRISPR and Prime

Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research | Military Medical Research

Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346(6213):1258096. Article  PubMed  Google Scholar  Doudna JA. The promise and challenge of therapeutic genome editing. Nature. 2020;578(7794):229–36. Article  CAS  PubMed  PubMed Central  Google Scholar  Nambiar TS, Baudrier L, Billon P, Ciccia A. CRISPR-based genome editing…

Continue Reading Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research | Military Medical Research

Viruses | Free Full-Text | Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2

Figure 1. Replication cycle of SARS-CoV-2 and genome organization. (A) The SARS-CoV-2 replication cycle. Binding of the viral S protein to the ACE-2 receptor triggers SARS-CoV-2 infection and the plus genomic RNA (+gRNA) is translated into polyprotein (pp)1a and pp1ab. These proteins are proteolytically cleaved to generate 16 non-structural proteins…

Continue Reading Viruses | Free Full-Text | Efficient CRISPR-Cas13d-Based Antiviral Strategy to Combat SARS-CoV-2

Electrochemical detection of the p53 gene using exponential amplification reaction (EXPAR) and CRISPR/Cas12a reactions

Levine AJ, Finlay CA, Hinds PW (2004) P53 is a tumor suppressor gene. Cell 116:S67–S69 Article  CAS  PubMed  Google Scholar  Sigal A, Rotter V (2000) Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Can Res 60:6788–6893 CAS  Google Scholar  Sammons MA, Nguyen T-AT,…

Continue Reading Electrochemical detection of the p53 gene using exponential amplification reaction (EXPAR) and CRISPR/Cas12a reactions

Portable rapid detection of maize chlorotic mottle virus using RT-RAA/CRISPR-Cas12a based lateral flow assay

Introduction Maize (Zea mays L.) is one of the most important cereal crops in the world. In 2011, a large outbreak of maize lethal necrosis disease (MLND) occurred in the Southern Rift Valley of Kenya (Wangai et al., 2012), caused up to 100% losses in maize yield, and affected the income…

Continue Reading Portable rapid detection of maize chlorotic mottle virus using RT-RAA/CRISPR-Cas12a based lateral flow assay

Sherlock obtains Cas12 CRISPR patent

Sherlock Biosciences, a company engineering biology to bring next-generation lab-quality diagnostic testing to the point of need, has announced that the U.S. Patent and Trademark Office (USPTO) has granted a patent for the diagnostic use of the Cas12 enzyme. Sherlock has exclusive U.S. rights to the patent from Shanghai-based Tolo…

Continue Reading Sherlock obtains Cas12 CRISPR patent

Sherlock Gains Patent Rights for Cas12 in Diagnostics

Bryan Dechairo, PhD, Sherlock Biosciences president and CEO Sherlock Biosciences has gained U.S. rights to a patent for diagnostic use of a CRISPR system based on the smaller Cas12 enzyme as single RNA-guided endonuclease. Sherlock—whose co-founders include CRISPR pioneer Feng Zhang, PhD, of the Broad Institute—says its exclusive U.S. rights to…

Continue Reading Sherlock Gains Patent Rights for Cas12 in Diagnostics

Sherlock Biosciences nabs patent rights to Cas12 enzyme for CRISPR diagnostics

Sherlock Biosciences said on Tuesday that the U.S. Patent and Trademark Office (USPTO) has granted a patent for the diagnostic use of the Cas12 enzyme, an integral part of the firm’s diagnostic testing technology. Sherlock has exclusive U.S. rights to the patent from Shanghai-based Tolo Biotech, as well as to…

Continue Reading Sherlock Biosciences nabs patent rights to Cas12 enzyme for CRISPR diagnostics

Sherlock at Apex of CRISPR-based Diagnostics after USPTO Grants Earliest Priority Patent

Preeminent IP position gives Sherlock freedom to operate and commercialize across multiple CRISPR business avenues WATERTOWN, Mass., Feb. 21, 2023 /PRNewswire/ — Sherlock Biosciences, a company engineering biology to bring next-generation lab-quality diagnostic testing to the point of need, today announced that the U.S. Patent and Trademark Office (USPTO) has…

Continue Reading Sherlock at Apex of CRISPR-based Diagnostics after USPTO Grants Earliest Priority Patent

News: Researchers at Johns Hopkins and USCD Report Novel CRISPR-Cas13d Therapy for Huntington’s Disease

Dr. Wenzhen Duan (left), Professor of Psychiatry and Behavioural Science at Johns Hopkins University School of Medicine, and Dr. Gene Yeo (right), Professor of Cellular and Molecular Medicine at the University of California San Diego, have created a novel CRISPR-Cas13d based therapy for Huntington’s Disease that depletes mutant Huntingtin transcripts…

Continue Reading News: Researchers at Johns Hopkins and USCD Report Novel CRISPR-Cas13d Therapy for Huntington’s Disease

Bacteriophage discovery to advance biotechnology and biotherapeutics

Work by Adler et al.2 describes a 2-step in vitro technique for efficient genome editing of phages involving the broad-spectrum bacterial CRISPR–Cas13a. Cas13 effectors are RNA-guided RNA nucleases with catalytic activity against 2 higher eukaryotic and prokaryotic nucleotide-binding domains. The authors elegantly demonstrated how the Cas13a system from Leptotrichia buccalis…

Continue Reading Bacteriophage discovery to advance biotechnology and biotherapeutics

Cas13a (L. buccalis) Recombinant

● Description Recombinant L. buccalis LbuCas13a (type VI-A CRISPR-associated RNA-guided ribonuclease Cas13a), tag free. Cas13a is an RNA-guided endonuclease that belongs to the class 2 type VI CRISPR-Cas system. When activated, Cas13a induces collateral cleavage of nearby non-targeted RNAs in a nonspecific manner. ● Product Data Gallery 4-20% SDS-PAGE Coomassie…

Continue Reading Cas13a (L. buccalis) Recombinant

CRISPR-Cas13d effectively targets SARS-CoV-2 variants, including Delta and Omicron, and inhibits viral infection

doi: 10.1002/mco2.208. eCollection 2023 Feb. Zongzhi Liu  1   2   3 , Xiang Gao  4 , Chuanwen Kan  2   5 , Lingyu Li  1   2   3 , Yuan Zhang  6 , Yibo Gao  7 , Shengyuan Zhang  4 , Liangji Zhou  6 , Hui Zhao  6   8   9 , Mingkun Li  2  …

Continue Reading CRISPR-Cas13d effectively targets SARS-CoV-2 variants, including Delta and Omicron, and inhibits viral infection

Gene Editing: CRISPR Therapeutics vs. Beam Therapeutics

Gene Editing Hype Gene editing has for a while been hailed as the new frontier in medicine. The peak enthusiasm for investors on this topic was in early 2020, with the related stocks having cool off since. No matter the market sentiment, gene editing is still a big deal for…

Continue Reading Gene Editing: CRISPR Therapeutics vs. Beam Therapeutics

a rising star in plant biology

Abdelmohsen, K., Panda, A.C., Munk, R., Grammatikakis, I., Dudekula, D.B., De, S., Kim, J., Noh, J.H., Kim, K.M., Martindale, J.L. et al., 2017. Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1. RNA Biol. 14, 361-369 Aktas,…

Continue Reading a rising star in plant biology

The collateral activity of RfxCas13d can induce lethality in a RfxCas13d knock-in mouse model

Background: The CRISPR-Cas13 system is an RNA-guided RNA-targeting system and has been widely used in transcriptome engineering with potentially important clinical applications. However, it is still controversial whether Cas13 exhibits collateral activity in mammalian cells. Results: Here, we find that knocking down gene expression using RfxCas13d in the adult brain…

Continue Reading The collateral activity of RfxCas13d can induce lethality in a RfxCas13d knock-in mouse model

Development and clinical evaluation of a CRISPR/Cas13a-based diagnostic test to detect Mycobacterium tuberculosis in clinical specimens

Introduction Tuberculosis (TB), caused by Mycobacterium tuberculosis (MTB) complex, remains one of the leading infectious causes of death worldwide, with an estimated 1.6 million TB deaths in 2021 (World Health Organization, 2022). Rapid and accurate TB diagnosis is critical to ensure timely initiation of anti-TB therapy (Walzl et al., 2018)….

Continue Reading Development and clinical evaluation of a CRISPR/Cas13a-based diagnostic test to detect Mycobacterium tuberculosis in clinical specimens

Sherlock Biosciences Acquires Sense Biodetection to Commercialize Disposable CRISPR-Based Diagnostics

Sherlock Biosciences has bought global molecular diagnostics company Sense Biodetection based out of Cambridge, U.K., to help it reach its goal of making diagnostics easy to use, cheap, disposable, and good for the environment. Sherlock’s purchase of Sense—which launched its fully integrated molecular diagnostic test that provides laboratory-quality results in…

Continue Reading Sherlock Biosciences Acquires Sense Biodetection to Commercialize Disposable CRISPR-Based Diagnostics

Cryo-EM structure and protease activity of the type III-E CRISPR-Cas effector

Hampton, H. G., Watson, B. N. J. & Fineran, P. C. The arms race between bacteria and their phage foes. Nature 577, 327–336 (2020). Article  CAS  Google Scholar  Makarova, K. S. et al. Evolution and classification of the CRISPR-Cas systems. Nat. Rev. Microbiol. 9, 467–477 (2011). Article  CAS  Google Scholar …

Continue Reading Cryo-EM structure and protease activity of the type III-E CRISPR-Cas effector

What Is CRISPR-Cas12a2? & Why Does It Matter?

A Brief History of CRISPR CRISPR are genetic sequences found in bacteria, which use them as a defense mechanism against viruses called bacteriophages. It essentially targets the virus’s genetic material to stop its propagation. CRISPR molecules can be used together with the Cas9 protein (Cas mean CRISPR Associated Protein) to…

Continue Reading What Is CRISPR-Cas12a2? & Why Does It Matter?

CSIRO hiring CSIRO Postdoctoral Fellowship in Anti-Viral Bioinformatics in Canberra, Australian Capital Territory, Australia

Acknowledgement of CountryCSIRO acknowledges the Traditional Owners of the land, sea and waters, of the area that we live and work on across Australia. We acknowledge their continuing connection to their culture and pay our respects to their Elders past and present. View our vision towards reconciliation The Opportunity Do…

Continue Reading CSIRO hiring CSIRO Postdoctoral Fellowship in Anti-Viral Bioinformatics in Canberra, Australian Capital Territory, Australia

How to modify the genes of nature’s master manipulators

CRISPR, the Nobel Prize-winning gene-editing technology, is poised to once again have a profound impact on the fields of microbiology and medicine. A team led by CRISPR pioneer Jennifer Doudna and her longtime collaborator Jill Banfield has developed a clever tool to edit the genomes of bacteria-infecting viruses called bacteriophages…

Continue Reading How to modify the genes of nature’s master manipulators

731 Type VI A Cas13a In Cas13a direct repeat region of crRNA is composed of 5 6

7.3.1Type VI-A (Cas13a)In Cas13a, direct repeat region of crRNA is composed of 5–6 bp stem using Watsonand Crick base pairing with an unpaired 2 nt bulge (AA or AC) present at 30end ofstem, while loop region of stem contains 7–9 nt depending upon homologs ofCas13a. In addition, an 8–12 nt…

Continue Reading 731 Type VI A Cas13a In Cas13a direct repeat region of crRNA is composed of 5 6

CRISPR Could Make Testing for SARS-COV-2 Fast and Easy

An engineered CRISPR-based method that finds RNA from SARS-CoV-2, the virus that causes COVID-19, promises to make testing for that and other diseases fast and easy, researchers report. The researchers further engineered the RNA-editing CRISPR-Cas13 system to boost their power for detecting minute amounts of the SARS-CoV-2 virus in biological…

Continue Reading CRISPR Could Make Testing for SARS-COV-2 Fast and Easy

Engineered LwaCas13a with enhanced collateral activity for nucleic acid detection

doi: 10.1038/s41589-022-01135-y. Online ahead of print. Jie Yang #  1 , Yang Song #  2   3 , Xiangyu Deng  4 , Jeffrey A Vanegas  1 , Zheng You  1 , Yuxuan Zhang  2   3 , Zhengyan Weng  2   3 , Lori Avery  5 , Kevin D Dieckhaus  6 , Advaith Peddi  4 , Yang Gao  7 , Yi Zhang  8…

Continue Reading Engineered LwaCas13a with enhanced collateral activity for nucleic acid detection

The crisprVerse: a comprehensive Bioconductor ecosystem for the design of CRISPR guide RNAs across nucleases and technologies

Abstract The success of CRISPR-mediated gene perturbation studies is highly dependent on the quality of gRNAs, and several tools have been developed to enable optimal gRNA design. However, these tools are not all adaptable to the latest CRISPR modalities or nucleases, nor do they offer comprehensive annotation methods for advanced…

Continue Reading The crisprVerse: a comprehensive Bioconductor ecosystem for the design of CRISPR guide RNAs across nucleases and technologies

Dynamic mechanisms of CRISPR interference by Escherichia coli CRISPR-Cas3

In vitro reconstitution of Escherichia coli CRISPR-Cas3 interference E. coli CRISPR-Cas3 is generally well-characterized type I CRISPR complexes in vitro and in vivo32,33,37,38. However, recombinant EcoCas3 protein is difficult to purify because of poor solubility and propensity to aggregate at 37 °C25,26,30,39. Co-expression of HtpG chaperon40 and/or low temperature growth at…

Continue Reading Dynamic mechanisms of CRISPR interference by Escherichia coli CRISPR-Cas3

Global Genome Editing Market Report 2022: Developing Biotechnology Industry in Emerging Regions Presents Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Genome Editing Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Technology, Application, and End User” report has been added to ResearchAndMarkets.com‘s offering. The genome editing market is projected to reach US$ 16,986.69 million by 2028 from US$ 5,199.40 million in 2021; it is expected to…

Continue Reading Global Genome Editing Market Report 2022: Developing Biotechnology Industry in Emerging Regions Presents Opportunities – ResearchAndMarkets.com

Beam Therapeutics Stock: A Leader in Gene Editing Tech?

Don’t invest in stories. Don’t invest in a company before they have meaningful revenues. Don’t invest in drug developers that have a great deal of regulatory risk. These are all rules we need to break if we want exposure to a technology that allows mankind to start playing with the…

Continue Reading Beam Therapeutics Stock: A Leader in Gene Editing Tech?

Frontiers | A Mutated Nme1Cas9 Is a Functional Alternative RNase to Both LwaCas13a and RfxCas13d in the Yeast S. cerevisiae

Introduction The clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-associated (Cas) protein systems naturally exist in prokaryotes. They are RNA-mediated defense mechanisms to protect bacteria and archaea from invading nucleic acids (Barrangou et al., 2007). CRISPR–Cas systems are classified into two classes (1 and 2). Class 2 CRISPR–Cas require a single…

Continue Reading Frontiers | A Mutated Nme1Cas9 Is a Functional Alternative RNase to Both LwaCas13a and RfxCas13d in the Yeast S. cerevisiae

Convenience-sized RNA editing | MIT News

Last year, researchers at MIT’s McGovern Institute for Brain Research discovered and characterized Cas7-11, the first CRISPR enzyme capable of making precise, guided cuts to strands of RNA without harming cells in the process. Now, working with collaborators at the University of Tokyo, the same team has revealed that Cas7-11…

Continue Reading Convenience-sized RNA editing | MIT News

A Highly Sensitive and Specific Detection Method for Mycobacterium tuberculosis Fluoroquinolone Resistance Mutations Utilizing the CRISPR-Cas13a System

Objectives CRISPR-Cas13a system-based nucleic acid detection methods are reported to have rapid and sensitive DNA detection. However, the screening strategy for crRNAs that enables CRISPR-Cas13a single-base resolution DNA detection of human pathogens remains unclear. Methods A combined rational design and target mutation-anchoring CRISPR RNA (crRNA) screening strategy was proposed. Results…

Continue Reading A Highly Sensitive and Specific Detection Method for Mycobacterium tuberculosis Fluoroquinolone Resistance Mutations Utilizing the CRISPR-Cas13a System

Using CRISPR/Cas to develop biosafety materials

The diagnosis and treatment of viral infections, especially those that cause large-scale outbreaks, is urgently needed, as the lack of these measures allows epidemics to progress. A new Biosafety and Health study discusses the use of the highly efficient clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated proteins (Cas) technology to…

Continue Reading Using CRISPR/Cas to develop biosafety materials

A genome-scale screen for synthetic drivers of T cell proliferation

Abramson, J. S. et al. Transcend NHL 001: immunotherapy with the CD19-directed CAR T-cell product JCAR017 results in high complete response rates in relapsed or refractory B-cell non-Hodgkin lymphoma. Blood 128, 4192–4192 (2016). Google Scholar  Shifrut, E. et al. Genome-wide CRISPR screens in primary human T cells reveal key regulators…

Continue Reading A genome-scale screen for synthetic drivers of T cell proliferation

Development of Cas12a-Based Cell-Free Small-Molecule Biosensors via Allosteric Regulation of CRISPR Array Expression

In nature, microbes have evolved different systems to sense external stimuli. Synthetic biology approaches (1) repurpose these systems as biosensors to specifically and sensitively detect various targets of interest. Although various highly sensitive and specific laboratory-based analytical methods (including high-performance liquid chromatography and mass spectrometry) can detect small-molecule targets, they…

Continue Reading Development of Cas12a-Based Cell-Free Small-Molecule Biosensors via Allosteric Regulation of CRISPR Array Expression

Seven technologies to watch in 2022

The Telomere-to-Telomere Consortium is sequencing whole chromosomes.Credit: Adrian T. Sumner/SPL From gene editing to protein-structure determination to quantum computing, here are seven technologies that are likely to have an impact on science in the year ahead. Fully finished genomes Roughly one-tenth of the human genome remained uncharted when genomics researchers…

Continue Reading Seven technologies to watch in 2022

Newly discovered protein essential for CRISPR/Cas3 genome editing

24 January 2022 A hidden component of the CRISPR/Cas3 genome editing system, which is essential for it to work, has been discovered by scientists. The CRISPR/Cas3 family of genome editing systems is similar to other CRISPR families but can uniquely make larger and more accurate changes to DNA (see BioNews…

Continue Reading Newly discovered protein essential for CRISPR/Cas3 genome editing

Collateral cleavage of 28s rRNA by RfxCas13d causes death of mice

Abstract Summary The CRISPR-Cas13 system is an RNA-guided RNA-targeting system, and has been widely used in transcriptome engineering with potentially important clinical applications. However, it is still controversial whether Cas13 exhibits collateral activity in mammalian cells. Here, we found that knocking down gene expression using RfxCas13d in the adult brain…

Continue Reading Collateral cleavage of 28s rRNA by RfxCas13d causes death of mice

RNA-targeting enzyme expands the CRISPR toolkit

McGovern Fellows Jonathan Gootenberg (left) and Omar Abudayyeh in their lab. Credit: Caitlin Cunningham Researchers at MIT’s McGovern Institute for Brain Research have discovered a bacterial enzyme that they say could expand scientists’ CRISPR toolkit, making it easy to cut and edit RNA with the kind of precision that, until…

Continue Reading RNA-targeting enzyme expands the CRISPR toolkit

Jennifer Doudna’s CRISPR startup Mammoth Biosciences goes unicorn

The gene-editing tool CRISPR is moving toward the market, promising better tests, disease cures — and maybe even a woolly mammoth. The big picture: CRISPR is already a historic scientific achievement, but we’re just now entering the moment when it will begin to impact patients and possibly the planet. Driving…

Continue Reading Jennifer Doudna’s CRISPR startup Mammoth Biosciences goes unicorn

CRISPR Convenience: Cas7-11 Redefines RNA Editing

Scientists, typically, are on their own after their post-doc ends. Sometimes, albeit rarely, they team up, blending their ideas, money, and people. Connie Cepko, PhD, and Cliff Tabin, PhD, pioneered the idea of a lab partnership, spending the last few decades working together in their shared lab at Harvard Medical…

Continue Reading CRISPR Convenience: Cas7-11 Redefines RNA Editing

Industry Trends and Global Forecasts, 2021-2030

INTRODUCTION Clustered regularly interspaced short palindromic repeats (CRISPR) are a family of DNA sequences, which constitute a primitive immune system that is responsible for protecting prokaryotic cells from phage infections. New York, Aug. 24, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “CRISPR Based Therapeutics Market by…

Continue Reading Industry Trends and Global Forecasts, 2021-2030